6Chang DJ,Desjardins PJ,King TR,et al.The analgesic efficacy of etoricoxib compared with oxycodone/acetamino phen in an acute postoperative pain model:a randomized,double-blind clinical trial[J].Anesth Analg,2004,99(3):807-815.
7Sutaria S,Katbamna R,Underwood M.Effectiveness of interventions for the treatment of acute and prevention of recurrent gout-a systematic review[J].Rheumatology (Oxford),2006,45(11):1422-1431.
8Loren L,Sean PC,Byron C,et al.Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme:a randomised comparison[J].Lancet,2007,369(9560):465-473.
9Loren L,Sean P,Curti S,et al.Lower gastrointestinal events in a double-blind Trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal antiinflammatory drug diclofenac[J].Gastroenterology,2008,135(5):1517-1525.
10Henry K,Sean PC,Amarjot K,et al.Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac:multivariate analysis of the MEDAL program[J].European Journal of Heart Failure,2009,11 (6):542-550.
